Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Emond

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Urology Practice|August 18, 2023
Assessment of Evidence-Based Standards in the Treatment of Advanced Prostate Cancer in a Community PracticeDominic Pilon, Lorie A Ellis, Ajay S Behl, et al.
Journal of Medical Economics|February 23, 2024
Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancerChristine M Bestvina, Dexter Waters, Laura Morrison, et al.
Journal of the International AIDS Society|June 12, 2023
Incidence of cardiometabolic outcomes among people living with HIV-1 initiated on integrase strand transfer inhibitor versus non-integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the United StatesPeter F Rebeiro, Bruno Emond, Carmine Rossi, et al.
Current Medical Research and Opinion|February 23, 2018
Real-world evaluation of Hba1c, blood pressure, and weight loss among patients with type 2 diabetes mellitus treated with canagliflozin: an analysis of electronic medical records from a network of hospitals in FloridaDamon Tanton, Mei Sheng Duh, Marie-Hélène Lafeuille, et al.
Journal of Health Economics and Outcomes Research|September 2, 2025
Healthcare Resource Use, Healthcare Costs, and Unmet Needs Among Patients Treated for EGFR-Mutated Advanced or Metastatic Non-small Cell Lung CancerDavid Waterhouse, Iris Li, Laura Morrison, et al.
Journal of Diabetes and Its Complications|December 18, 2018
An investigation into the durability of glycemic control in patients with type II diabetes initiated on canagliflozin or sitagliptin: A real-world analysis of electronic medical recordsCarol H Wysham, Patrick Lefebvre, Dominic Pilon, et al.
Current Medical Research and Opinion|January 12, 2016
Comparison of Medicaid spending in schizoaffective patients treated with once monthly paliperidone palmitate or oral atypical antipsychoticsYongling Xiao, Erik Muser, Dong-Jing Fu, et al.
Oncology and Therapy|June 28, 2026
IMMPACT-MM: Insights into Multiple Myeloma Patient Outcomes following Early-Line Cilta-cel TreatmentSridevi Rajeeve, Saurabh P Nagar, Sabyasachi Ghosh, et al.
Current Medical Research and Opinion|February 7, 2022
Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximabIris Lin, Richard Melsheimer, Rachel H Bhak, et al.
Schizophrenia (Heidelberg, Germany)|February 11, 2023
Comparison of clinical outcomes in patients with schizophrenia following different long-acting injectable event-driven initiation strategiesChristoph U Correll, Carmela Benson, Bruno Emond, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Urology Practice|August 18, 2023
Assessment of Evidence-Based Standards in the Treatment of Advanced Prostate Cancer in a Community PracticeDominic Pilon, Lorie A Ellis, Ajay S Behl, et al.
Journal of Medical Economics|February 23, 2024
Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancerChristine M Bestvina, Dexter Waters, Laura Morrison, et al.
Journal of the International AIDS Society|June 12, 2023
Incidence of cardiometabolic outcomes among people living with HIV-1 initiated on integrase strand transfer inhibitor versus non-integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the United StatesPeter F Rebeiro, Bruno Emond, Carmine Rossi, et al.
Current Medical Research and Opinion|February 23, 2018
Real-world evaluation of Hba1c, blood pressure, and weight loss among patients with type 2 diabetes mellitus treated with canagliflozin: an analysis of electronic medical records from a network of hospitals in FloridaDamon Tanton, Mei Sheng Duh, Marie-Hélène Lafeuille, et al.
Journal of Health Economics and Outcomes Research|September 2, 2025
Healthcare Resource Use, Healthcare Costs, and Unmet Needs Among Patients Treated for EGFR-Mutated Advanced or Metastatic Non-small Cell Lung CancerDavid Waterhouse, Iris Li, Laura Morrison, et al.
Journal of Diabetes and Its Complications|December 18, 2018
An investigation into the durability of glycemic control in patients with type II diabetes initiated on canagliflozin or sitagliptin: A real-world analysis of electronic medical recordsCarol H Wysham, Patrick Lefebvre, Dominic Pilon, et al.
Current Medical Research and Opinion|January 12, 2016
Comparison of Medicaid spending in schizoaffective patients treated with once monthly paliperidone palmitate or oral atypical antipsychoticsYongling Xiao, Erik Muser, Dong-Jing Fu, et al.
Oncology and Therapy|June 28, 2026
IMMPACT-MM: Insights into Multiple Myeloma Patient Outcomes following Early-Line Cilta-cel TreatmentSridevi Rajeeve, Saurabh P Nagar, Sabyasachi Ghosh, et al.
Current Medical Research and Opinion|February 7, 2022
Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximabIris Lin, Richard Melsheimer, Rachel H Bhak, et al.
Schizophrenia (Heidelberg, Germany)|February 11, 2023
Comparison of clinical outcomes in patients with schizophrenia following different long-acting injectable event-driven initiation strategiesChristoph U Correll, Carmela Benson, Bruno Emond, et al.
Pageof 8